Annual Short Term Debt
$15.60 M
+$14.66 M+1566.45%
December 31, 2023
Summary
- As of February 7, 2025, AUPH annual short term debt is $15.60 million, with the most recent change of +$14.66 million (+1566.45%) on December 31, 2023.
- During the last 3 years, AUPH annual short term debt has risen by +$14.81 million (+1879.44%).
- AUPH annual short term debt is now at all-time high.
Performance
AUPH Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
$15.95 M
+$1.03 M+6.91%
September 30, 2024
Summary
- As of February 7, 2025, AUPH quarterly short term debt is $15.95 million, with the most recent change of +$1.03 million (+6.91%) on September 30, 2024.
- Over the past year, AUPH quarterly short term debt has increased by +$1.03 million (+6.91%).
- AUPH quarterly short term debt is now at all-time high.
Performance
AUPH Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
AUPH Short Term Debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +1566.5% | +6.9% |
3 y3 years | +1879.4% | +1636.9% |
5 y5 years | - | +1636.9% |
AUPH Short Term Debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +1566.5% | at high | +1636.9% |
5 y | 5-year | at high | -100.0% | at high | -100.0% |
alltime | all time | at high | -100.0% | at high | -100.0% |
Aurinia Pharmaceuticals Short Term Debt History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $15.95 M(+6.9%) |
Jun 2024 | - | $14.91 M(+1.3%) |
Mar 2024 | - | $14.72 M(-5.6%) |
Dec 2023 | $15.60 M(+1566.5%) | $15.60 M(+9.0%) |
Sep 2023 | - | $14.31 M(-4.4%) |
Jun 2023 | - | $14.97 M(+1484.1%) |
Mar 2023 | - | $945.00 K(+1.0%) |
Dec 2022 | $936.00 K(-11.6%) | $936.00 K(+2.0%) |
Sep 2022 | - | $918.00 K(-3.7%) |
Jun 2022 | - | $953.00 K(-5.6%) |
Mar 2022 | - | $1.01 M(-4.7%) |
Dec 2021 | $1.06 M(+34.4%) | $1.06 M(-4.7%) |
Sep 2021 | - | $1.11 M(-0.1%) |
Jun 2021 | - | $1.11 M(+3.4%) |
Mar 2021 | - | $1.07 M(+36.4%) |
Dec 2020 | $788.00 K(>+9900.0%) | $788.00 K(>+9900.0%) |
Dec 2019 | $0.00(-100.0%) | $0.00(-100.0%) |
Sep 2019 | - | $125.00 K(+2.5%) |
Jun 2019 | - | $122.00 K(+15.1%) |
Mar 2019 | - | $106.00 K(+1259.0%) |
Sep 2013 | - | $7800.00(-65.8%) |
Jun 2013 | - | $22.80 K(-17.1%) |
Mar 2013 | - | $27.50 K(-43.6%) |
Sep 2012 | - | $48.80 K(+5.6%) |
Jun 2012 | - | $46.20 K(+0.2%) |
Mar 2012 | - | $46.10 K(+4.5%) |
Dec 2011 | $44.10 K(-99.1%) | $44.10 K(-65.5%) |
Sep 2010 | - | $127.90 K(+826.8%) |
Jun 2009 | - | $13.80 K(-99.2%) |
Mar 2009 | - | $1.68 M(-64.6%) |
Dec 2008 | $4.75 M(+792.6%) | $4.75 M(+34.5%) |
Sep 2008 | - | $3.53 M(+42.5%) |
Jun 2008 | - | $2.48 M(+945.1%) |
Mar 2008 | - | $237.10 K(-55.4%) |
Dec 2007 | $532.20 K | $532.20 K(-42.6%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2007 | - | $927.70 K(-29.4%) |
Jun 2007 | - | $1.31 M(-19.2%) |
Mar 2007 | - | $1.63 M(-5.6%) |
Dec 2006 | $1.72 M(+6.0%) | $1.72 M(+0.4%) |
Sep 2006 | - | $1.72 M(+21.9%) |
Jun 2006 | - | $1.41 M(-15.8%) |
Mar 2006 | - | $1.67 M(+2.9%) |
Dec 2005 | $1.62 M(+15.8%) | $1.62 M(+10.0%) |
Sep 2005 | - | $1.48 M(+2.5%) |
Jun 2005 | - | $1.44 M(+8.7%) |
Mar 2005 | - | $1.33 M(-5.5%) |
Dec 2004 | $1.40 M(+652.0%) | $1.40 M(+46.4%) |
Sep 2004 | - | $958.60 K(+470.6%) |
Jun 2004 | - | $168.00 K(-10.4%) |
Mar 2004 | - | $187.60 K(+0.5%) |
Dec 2003 | $186.60 K(+42.6%) | $186.60 K(-22.1%) |
Sep 2003 | - | $239.60 K(-2.2%) |
Jun 2003 | - | $245.00 K(+31.2%) |
Mar 2003 | - | $186.70 K(+42.6%) |
Dec 2002 | $130.90 K(+84.4%) | $130.90 K(-0.6%) |
Sep 2002 | - | $131.70 K(-3.5%) |
Jun 2002 | - | $136.50 K(+0.3%) |
Mar 2002 | - | $136.10 K(+283.4%) |
Dec 2001 | $71.00 K(+47.3%) | - |
Aug 2001 | - | $35.50 K(-10.6%) |
May 2001 | - | $39.70 K(-8.9%) |
Feb 2001 | - | $43.60 K(-9.5%) |
Nov 2000 | $48.20 K(-29.0%) | $48.20 K(-53.9%) |
Aug 2000 | - | $104.60 K(-21.6%) |
May 2000 | - | $133.50 K(+93.8%) |
Feb 2000 | - | $68.90 K(+1.5%) |
Nov 1999 | $67.90 K(-65.2%) | $67.90 K(+1.5%) |
Aug 1999 | - | $66.90 K(-93.0%) |
May 1999 | - | $949.50 K(+104.6%) |
Feb 1999 | - | $464.00 K |
Nov 1998 | $195.30 K | - |
FAQ
- What is Aurinia Pharmaceuticals annual short term debt?
- What is the all time high annual short term debt for Aurinia Pharmaceuticals?
- What is Aurinia Pharmaceuticals annual short term debt year-on-year change?
- What is Aurinia Pharmaceuticals quarterly short term debt?
- What is the all time high quarterly short term debt for Aurinia Pharmaceuticals?
- What is Aurinia Pharmaceuticals quarterly short term debt year-on-year change?
What is Aurinia Pharmaceuticals annual short term debt?
The current annual short term debt of AUPH is $15.60 M
What is the all time high annual short term debt for Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals all-time high annual short term debt is $15.60 M
What is Aurinia Pharmaceuticals annual short term debt year-on-year change?
Over the past year, AUPH annual short term debt has changed by +$14.66 M (+1566.45%)
What is Aurinia Pharmaceuticals quarterly short term debt?
The current quarterly short term debt of AUPH is $15.95 M
What is the all time high quarterly short term debt for Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals all-time high quarterly short term debt is $15.95 M
What is Aurinia Pharmaceuticals quarterly short term debt year-on-year change?
Over the past year, AUPH quarterly short term debt has changed by +$1.03 M (+6.91%)